We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
| $6.5M | 0.03% |
+89,271
| New | +$6.44M |
|
|
NTT
402
DELISTED
Nippon Telegraph & Telephone
NTT
| $6.46M | 0.03% |
142,954
+1,828
| +1% | +$82.6K |
|
403
Energy Transfer Partners
ET
$70.1B
| $6.34M | 0.03% |
363,652
+11,758
| +3% | +$209K |
|
404
Crane NXT
CXT
$3.04B
| $6.34M | 0.03% |
185,474
-7,223
| -4% | -$224K |
|
405
Nucor
NUE
$56.4B
| $6.15M | 0.02% |
96,974
+14,042
| +17% | +$899K |
|
406
Zions Bancorporation
ZION
$10.1B
| $6.14M | 0.02% |
122,510
-21,835
| -15% | -$1.15M |
|
407
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $6.12M | 0.02% |
+118,176
| New | +$6.17M |
|
408
Capri Holdings
CPRI
$1.77B
| $6.06M | 0.02% |
88,461
-21,991
| -20% | -$1.54M |
|
409
Deere & Co
DE
$170B
| $6.05M | 0.02% |
40,274
-1,659
| -4% | -$238K |
|
410
NVIDIA
NVDA
$5.01T
| $5.92M | 0.02% |
842,600
-138,080
| -14% | -$898K |
|
411
iShares Russell Mid-Cap Value ETF
IWS
$15.5B
| $5.9M | 0.02% |
+65,409
| New | +$5.92M |
|
412
Expeditors International
EXPD
$22.9B
| $5.84M | 0.02% |
79,425
-10,251
| -11% | -$757K |
|
413
Zoetis
ZTS
$31.6B
| $5.8M | 0.02% |
63,355
+18,317
| +41% | +$1.62M |
|
414
Citigroup
C
$222B
| $5.8M | 0.02% |
80,835
-8,055
| -9% | -$569K |
|
415
SLM Corp
SLM
$4.57B
| $5.63M | 0.02% |
504,857
+198,657
| +65% | +$2.3M |
|
416
Conagra Brands
CAG
$7.07B
| $5.59M | 0.02% |
164,730
+116,770
| +243% | +$4.27M |
|
417
BP
BP
$113B
| $5.55M | 0.02% |
126,224
+2,276
| +2% | +$95.2K |
|
418
Barclays
BCS
$94.1B
| $5.48M | 0.02% |
640,836
-7,474
| -1% | -$69.3K |
|
419
Goldman Sachs
GS
$313B
| $5.4M | 0.02% |
24,082
+1,411
| +6% | +$328K |
|
420
Vanguard FTSE Europe ETF
VGK
$30B
| $5.39M | 0.02% |
+95,951
| New | +$5.44M |
|
421
Cadence Design Systems
CDNS
$90B
| $5.37M | 0.02% |
118,570
-1,315
| -1% | -$59.9K |
|
422
ManpowerGroup
MAN
$2.39B
| $5.36M | 0.02% |
62,383
-345,125
| -85% | -$30.7M |
|
423
Pearson
PSO
$9.78B
| $5.34M | 0.02% |
463,968
+4,202
| +0.9% | +$49.2K |
|
|
UN
424
DELISTED
Unilever NV New York Registry Shares
UN
| $5.32M | 0.02% |
95,773
+4,273
| +5% | +$242K |
|
425
iShares Russell 3000 ETF
IWV
$19.4B
| $5.21M | 0.02% |
+30,244
| New | +$5.12M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.